Michael Jung, a UCLA distinguished professor of chemistry and biochemistry who is also a member of UCLA’s Jonsson Comprehensive Cancer Center, has been selected as the recipient of the 2019 American Association for Cancer Research Award for Outstanding Achievement in Chemistry in Cancer Research.

Jung designs molecules that do not exist in nature. Two molecules he has developed in his laboratory, approved by the U.S. Food and Drug Administration, are being used to treat thousands of men who have a serious form of prostate cancer.

Jung, associate dean for entrepreneurship and innovation at UCLA, will be recognized for his scientific achievements during the association’s annual meeting in Atlanta.

In 2017, Jung and his wife, Alice, endowed the Michael and Alice Jung Chair in Medicinal Chemistry and Drug Discovery to enable UCLA to hire a faculty member who will conduct drug discovery research with the goal of producing effective new pharmaceuticals.